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An elevated resting heart rate is one of the strongest predictors of cardiovascular mortality
and is independently associated with sudden cardiac death (SCD). Agents capable of
reducing heart rate without significant side effects are therefore of particular interest for
the prevention of SCD. Recent human and animal studies have shown that omega-3 fatty
acids can reduce heart rate. Our work has shown that omega-3 fatty acids significantly
reduce membrane electrical excitability of the cardiac myocyte by lowering its resting
membrane potential and the duration of the refractory period through inhibition of ion
channels. We propose that these actions may be the underlying mechanisms for the
omega-3 fatty acid-induced reduction of heart rate observed in both humans and animals.
The heart rate-lowering capability of omega-3 fatty acids may contribute to their preventive
effect against SCD.
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INTRODUCTION
The cardioprotective effects of omega-3 fatty acids have become
widely recognized. One of the most significant effects is the pre-
vention of sudden cardiac death (SCD) (de Lorgeril et al., 1994;
GISSI-Prevenzione, 1999; Marchioli et al., 2002; Leaf et al., 2005,
2003), which is generally defined as death within 1 h of the onset
of symptoms, and is most frequently caused by ventricular fibril-
lation. Although the underlying mechanisms for this preventive
effect are not yet well understood, the reduction of heart rate by
omega-3 fatty acids may be an important factor contributing to
decreased risk for SCD.
An elevated resting heart rate is one of the strongest predic-
tors of cardiovascular mortality. In particular, a resting heart rate
of >70–90 beats per minute (bpm) is independently associated
with SCD.Multiple prospective studies have shown that even after
adjusting for common cardiovascular health-related variables,
such as age, weight, smoking, alcohol consumption, diabetes,
blood pressure, physical activity, blood cholesterol, medications,
and socioeconomic status, elevated heart rate remains a risk fac-
tor for SCD and a predictor of time to cardiac death (Shaper
et al., 1993; Palatini et al., 1999). In the Framingham cohort,
cardiovascular and coronary mortality rates increased with pro-
gressively higher resting heart rates irrespective of age or sex,
although the fraction of SCD rose sharply in men 35–65 years
old (Kannel et al., 1987). In general, similar relationships between
heart rate and cardiovascular death exist in men and women, but
the association is weaker in women (Kannel et al., 1987; Palatini
et al., 1999). Interestingly, heart rate is predictive of SCD in men
both with and without a history of ischemic heart disease (IHD)
(Wannamethee et al., 1995), and in some cases this relationship
is even stronger in men without pre-existing IHD (Shaper et al.,
1993).
Given these consistent and robust findings, drugs or sup-
plements that reduce heart rate are of particular interest for
preventing SCD. In fact, studies that have examined outcomes
for patients with chronic heart failure have revealed that pharma-
cotherapy to reduce heart rate is associated with better outcomes
for at least 5 years (Franke et al., 2012). Beta-adrenergic blockers,
cardiotonic agents such as ivabradine, and ACE inhibitors have
been prescribed for the purpose of lowering heart rate and reduc-
ing mortality, though they may present adverse effects (Arshad
et al., 2008; Böhm et al., 2012). Thus, agents that are able to reduce
heart rate without significant side effects may be valuable for the
prevention of SCD. Omega-3 fatty acids, a class of essential nutri-
ents primarily found in fish oil consisting of eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA), have been consistently
shown to lower heart rate (Grimsgaard et al., 1998).
The relationship between omega-3 fatty acids and cardiovas-
cular disease is well studied, and has appeared inconsistent at
times (Hooper et al., 2006; Kromhout et al., 2010; Rizos et al.,
2012). Still, it is important to consider that there is strong mech-
anistic evidence supporting a protective effect of omega-3 fatty
acids on cardiovascular disease. In this review, I will provide an
overview of the evidence for the heart rate-lowering effects of
omega-3 fatty acids both in animals and humans, and explain
how findings from our in vitro work provide a likely mechanism
by which omega-3 fatty acids act on cardiac myocytes to reduce
heart rate.
REDUCTION OF HEART RATE BY OMEGA-3 FATTY ACIDS
The effect of omega-3 fatty acids on heart rate has been observed
in many different populations, both with and without cardiovas-
cular disease. A meta-analysis of 30 randomized, double-blind,
placebo-controlled trials concluded that fish oil consumption can
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significantly reduce heart rate (Mozaffarian et al., 2005). In par-
ticular, the effect was greater in people whose baseline heart rate
was higher: in the overall pooled estimate, fish oil decreased heart
rate by 1.6 bpm compared to placebo, but reduced heart rate by
2.5 bpm in trials with a median baseline heart rate of ≥ 69 bpm.
Furthermore, the ability of fish oil to reduce heart rate appeared to
depend on the length of treatment. When a trial lasted for more
than 12 weeks, fish oil reduced heart rate by 2.5 bpm. However,
when the trial lasted for less than 12 weeks, fish oil had little effect
on heart rate. Interestingly, this meta-analysis also confirmed that
heart rate reduction did not vary significantly by fish oil dose
(Mozaffarian et al., 2005). Furthermore, another randomized,
controlled trial on 18 men with a history of myocardial infarction
and ejection fractions of <40% showed that those given omega-
3 fatty acids experienced a 5 bpm reduction in resting heart rate
and an improved 1-min heart rate recovery after exercise (O’Keefe
et al., 2006).
In addition, several large-scale, population-based studies
showed that increased dietary fish and omega-3 fatty acid
intake was associated with a significant reduction in heart rate.
Dallongeville et al. (2003) analyzed 2 years of data on 9758 men
without coronary heart disease from France and Ireland, group-
ing the men into four statistical categories based on how much
fish they consumed per week (less than once, once, twice, and
more than twice/week). They found that heart rate decreased
across the categories of fish intake and was lower in fish con-
sumers than in non-consumers, even after adjustments for age,
location, level of education, physical activity, smoking habits,
alcohol consumption, body mass index, and antiarrhythmic med-
ications (Dallongeville et al., 2003). Studies by Mozaffarian and
colleagues further examined the associations between fish intake
and a variety of cardiac measures (Mozaffarian et al., 2006a,b).
Their results showed that high fish consumption is associated
with a heart rate reduction of approximately 3.2 bpm. They also
found that an estimated 1 g/day higher EPA + DHA intake was
associated with a heart rate reduction of 2.3 bpm. Functionally,
this improvement in heart rate (−3.2 bpm) corresponds to a
∼7.5% lower risk of SCD (Mozaffarian et al., 2006b).
Fish oil also effectively reduces heart rate during times of
increased cardiac demand such as exercise. A study of 25
Australian football players revealed that 6g/day of fish oil reduced
heart rate during submaximal exercise over a period of 5 weeks
(Buckley et al., 2009). Likewise, another randomized, placebo-
controlled study of 16 exceptionally fit male cyclists taking 8g/day
of fish oil for 8 weeks also found a reduction in heart rate during
exercise. Heart rate during incremental workloads to exhaus-
tion was lowered, as was peak heart rate, oxygen consumption,
and heart rate during steady submaximal exercise (Peoples et al.,
2008). However, decreased heart rate from fish oil during exercise
is not contingent on physical fitness; in a study of 65 sedentary,
overweight volunteers who consumed tuna fish oil for 12 weeks,
resting heart rate and heart rate response to submaximal exercise
were decreased (Ninio et al., 2008). Thus, fish oil reduced heart
rate both at rest and during the stress of exercise, irrespective of
the relative fitness level of the participant.
Another set of interesting findings comes from a popula-
tion perhaps the least likely to experience cardiovascular illness:
infants. Term infants treated with varying amounts of DHA in
their formulas for 12 months show that DHA supplementation
reduces heart rate compared to infants whose formula does not
contain DHA, with no evidence of a dose response (Pivik et al.,
2009; Colombo et al., 2011). These data are noteworthy in that
they reinforce the non-specific impact of fish oil on heart rate,
and suggest that almost any cohort may benefit from fish oil in
this manner.
Finally, Harris and colleagues performed a small prospective
study that provides a valuable indication of which mechanisms
are likely to underlie the omega-3 fatty acid-driven reduction in
heart rate. The group enrolled heart transplant patients, ensur-
ing that their transplants had occurred more than three months
prior and there had been no transplant-related hospitalizations
(Harris et al., 2006). The revealing aspect of this study is that
transplanted hearts are functionally denervated of the vagal nerve,
and thus devoid of sympathetic and parasympathetic inputs.
The patients were randomly assigned to receive either a corn
oil placebo or EPA/DHA for 4–6 months, and at the end of the
study the patients in the omega-3 fatty acid group had heart
rates on average 5.4 bpm lower than baseline, whereas the corn
oil group showed no change (Harris et al., 2006). These find-
ings suggest that omega-3 fatty acids impact heart rate at the
level of the myocardium itself, and are in particular consistent
with the idea that the voltage-gated ion channels that control
the pacemaker currents in the heart are influenced by omega-3
fatty acids.
Similar reductions in heart rate due to omega-3 fatty acids have
been observed in animals. In a rat model, animals fed a DHA-
enriched diet had lower heart rates than animals fed a control diet,
a pattern that was achieved by 2 months and maintained until the
end of the 32-week study (Ayalew-Pervanchon et al., 2007). In a
hyperinsulinemic model, rats fed a diet containing DHA showed
lower heart rates and a shortened QT interval as compared to rats
fed and EPA-rich diet (Rousseau et al., 2003). Similarly, in rabbits
fed a diet enriched with 2.5% (w/w) fish oil for three weeks, sinus
cycle length and heart rate were reduced compared to animals fed
a 2.5% oleic sunflower oil for the same period of time (Verkerk
et al., 2009). A series of studies by Billman and colleagues has
also provided important information about omega-3 fatty acids
and heart function. Omega-3 fatty acid infusions into 13 intact,
conscious, exercising dogs highly susceptible to ischemia-induced
ventricular fibrillation were able to prevent ventricular fibrilla-
tion in 10 of the 13 dogs tested. The antiarrhythmic effect was
associated with slowing of the heart rate, shortening of the QT
interval, reduction of the left ventricular systolic pressure, and
prolongation of the electrocardiographic atrial-ventricular con-
duction time (PR interval) (Billman et al., 1997). Additional work
showed that dietary omega-3 supplementation reduces resting
heart rate and increases heart rate variability in dogs with pre-
vious but healed myocardial infarction, as well as in dogs that are
either susceptible or resistant to ventricular fibrillation (Billman
and Harris, 2011; Billman, 2012). Moreover, these reductions
in baseline heart rate were maintained during challenges (i.e.,
exercise or acute myocardial ischemia), but omega-3 did not
alter the amount of change induced by challenge; these find-
ings are consistent with the idea that omega-3 supplementation
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FIGURE 1 | (Top panel) Effects of EPA and DHA on the contraction of isolated
neonatal rat cardiomyocytes. Perfusion of the myocytes with 5µM EPA (A) or
5µM DHA (B) reduced the beating rate by 50% within 2min, and addition of
BSA to the perfusion solution quickly reversed the effect. Tracing (C) shows a
similar effect of lidocaine (20µM) on the contraction of the cardiac myocytes.
(Bottom panel) Tracings show prevention and termination of arrhythmia by
EPA. Perfusion of the myocytes with a solution containing 7 AM Ca2+ (A, a) or
0.1mM ouabain (B, a) induced contracture and fibrillation before perfusion
with EPA. Washing the cells with medium (Ca2+ = 1.2mM) returned the
fibrillations to the original beating rate (not shown). Then the cells were
perfused with medium containing 7µM EPA. After 5–8min, when the beating
rate was slowed, addition of 7mM Ca2+ (A, b) or 0.1mM ouabain (B, b) failed
to induce contracture or fibrillation in the same cells. The slow beating rates
were subsequently returned to the original rates by perfusion with BSA (not
shown). (C) Alternatively, after induction of fibrillation by ouabain (0.1mM)
plus Ca2+ (5mM), addition of IEPA (8µM) terminated the fibrillation and led to
slow beating, and subsequent addition of BSA (2mg/ml), still in the presence
of ouabain and high external Ca2+ concentration, reinstated fibrillation.
impacts intrinsic heart rate rather than autonomic regulation of
the heart. Interestingly, there is also evidence that under certain
conditions omega-3 may actually be pro-arrhythmic by reduc-
ing myocyte excitability during acute regional ischemia (Coronel
et al., 2007).
Overall, it is apparent that a wide range of human and animal
subjects, with or without cardiac disease, all respond to omega-3
fatty acid supplementation with reductions in resting and stress-
induced heart rates. These findings suggest a highly consistent and
robust effect of omega-3 fatty acids on heart rate.
POTENTIAL MECHANISMS UNDERLYING THE HEART
RATE-LOWERING EFFECT OF OMEGA-3 FATTY ACIDS
Although omega-3 fatty acids may reduce heart rate through
several different mechanisms, our early studies demonstrated a
direct effect of omega-3 fatty acids on cardiac cell membrane
electrical excitability that contributes to reduced heart rate. We
used isolated, neonatal rat cardiac myocytes that retain sponta-
neous beating behavior, allowing us to assess the effect of EPA
and DHA on contraction as well as electrophysiological activity
without neural or hormonal input. We found that EPA and DHA
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promptly reduced the contraction rate of the cardiac myocytes by
50–80% without a significant change in the amplitude of the con-
tractions. This effect of omega-3 fatty acids on the excitability of
the cells was similar to that produced by the class I antiarrhythmic
drug lidocaine (Figure 1, top) (Kang and Leaf, 1994). In addition,
we showed that EPA and DHA can prevent as well as terminate
fibrillation, characterized by chaotic, asynchronous beating and
contractures, induced either by high extracellular calcium con-
centrations and/or ouabain (Figure 1, bottom) (Kang and Leaf,
1994). Inhibitors of fatty acidmetabolism, however, have no effect
on omega-3 fatty acid-induced heart cell contraction, indicat-
ing that the free fatty acids do not need to be metabolized into
byproducts to cause a reduction in heart rate (Kang and Leaf,
1994). The omega-3 fatty acid-induced reduction in the beating
rate could be readily reversed by cell perfusion with fatty acid-free
bovine serum albumin, indicating that omega-3 fatty acids likely
do not need to be incorporated into the membrane phospho-
lipid or covalently linked to membrane components in order to
be effective. These results suggest that omega-3 fatty acids in their
free form can suppress the automaticity of cardiac contraction
and thereby exert their heart rate-lowering effects.
The reduction of electrical excitability of cardiac myocytes
by omega-3 fatty acids can be demonstrated directly by their
response to electrical pacing (Kang and Leaf, 1996). As shown
in Figure 2, prior to addition of EPA to the cells, application
of a series of stimulating impulses elicited a rapid beating syn-
chronized with the impulse rate. 3–5min after perfusion of the
cells with 15 uM EPA, when a slowing of the beating rate had
occurred, application of the same (15V) or even stronger electri-
cal stimuli failed to boost the beating rate. When the cells were
washed with medium containing delipidated BSA (2mg/ml) for
2–3min, stimulation of the cells with 15V field strength induced
a response similar to that observed prior to addition of EPA
(Figure 2) (Kang and Leaf, 1996). These results further suggest
that omega-3 fatty acids have an inhibitory effect on the electrical
automaticity/excitability of the cardiac myocytes.
To better elucidate the mechanism of action of omega-3
fatty acids on heart rate, we employed a patch-clamp technique
FIGURE 2 | Effect of EPA on the response of cultured myocytes to
electrical pacing. Trace shows the response of cell contraction to the
electrical stimuli (as indicated by the bars above the contraction trace)
before perfusion with EPA (top trace), during perfusion with 15µM EPA
(middle trace) and after washout with BSA.
to examine the electrophysiological activity in isolated neona-
tal rat cardiac myocytes. First, we induced the action potential
in the myocytes exposed to EPA or DHA and measured the
strength of the current required to elicit an action potential
(Kang et al., 1995). We found that EPA increased the strength
of the depolarizing current needed to provoke an action poten-
tial and lengthened the cycle of excitability. These changes were
due to an increase in the threshold for action potential and a
more negative resting membrane potential. There was a pro-
gressive prolongation of intervals between spontaneous action
potentials and a slowed rate of phase 4 depolarization (Figure 3)
(Kang et al., 1995). These results demonstrate that omega-3 fatty
acids can indeed reduce membrane electrical excitability and
provide an electrophysiological basis for the heart rate-lowering
effects of free omega-3 fatty acids. These findings are consistent
with the observations that omega-3 fatty acids can profoundly
reduce the contraction rate of cardiac myocytes (Kang and Leaf,
1994).
At this point in our research, the manner by which omega-
3 fatty acids reduce membrane excitability was still unclear.
Therefore, we tested the effects of omega-3 fatty acids on single
ion channel activity in neonatal rat cardiac myocytes. The results
demonstrated a prompt inhibitory action of omega-3 fatty acids
on the Na+ currents through fast sodium channels responsible
for the phase 0 of the action potential in isolated neonatal rat
FIGURE 3 | (Top panel) Effect of EPA on holding voltage at constant
imposed current, threshold voltage, and current required to attain
action-potential threshold. Holding potential was initially set at −70mV, and
cells were stimulated with a series of depolarization pulses in 3- or 4-pA
increment at 10 s intervals. Recordings showing the holding
transmembrane potentials, the threshold potentials, and the currents
required to elicit an action potential in a cell before (Left) and after (Right)
exposure to 10µM EPA. (Bottom panel) The effect of EPA on the cycle
length of excitability. Cells were given a pair of superthreshold electrical
stimuli at 0.1 Hz (necessary to elicit action potential in the presence of EPA)
with various intervals from 500 to 1500ms in 100ms increments. Bars at
top indicate the time intervals between two stimuli. (A) Recording showing
the cycle length (600ms) before 10µM EPA exposure. (B) Recording
showing cycle length (1100ms) 3min after EPA exposure.
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cardiac myocytes. The inhibition of this ion channel was dose,
time, and voltage dependent, but not use dependent (Figure 4)
(Xiao et al., 1995). Subsequent studies have demonstrated that
other ion channels, such as calcium channels, can also be affected
by omega-3 fatty acids to varying degrees (Leaf, 2001). These find-
ings provided the ionic basis for the marked electrophysiological
effects of omega-3 fatty acids on myocytes, and explained why
omega-3 fatty acids are capable of reducing heart rate.
CONCLUSIONS
Regulation of heart rate in humans is highly complex.
Sympathetic output, vagal tone, and systolic and diastolic left ven-
tricular function are only a few of the factors that contribute to the
regulation of heart rate. While omega-3 fatty acids could poten-
tially affect any or all of these factors, our studies strongly suggest
a direct impact of omega-3 fatty acids (Leaf et al., 1999a,b). Our
cellular work has shown that omega-3 fatty acids significantly
reduce membrane electrical excitability of the cardiac myocyte
by lowering its resting membrane potential and the duration of
the refractory period through inhibition of ion channels. We pro-
pose that these actions may be the underlying mechanisms for the
omega-3 fatty acid-induced reduction of heart rate observed in
both humans and animals. Given the close relationship between
heart rate and SCD, the direct impact of omega-3 fatty acids on
the cardiac membrane to reduce heart rate may be a critical deter-
minant of the preventive effect of omega-3 fatty acids against
SCD. Thus, increasing intake of omega-3 fatty acids would likely
benefit individuals at risk for SCD.
FIGURE 4 | EPA suppresses the voltage-activated Na+ current (INa)
in a representative cultured neonatal rat ventricular myocyte.
(Upper) Superimposed traces in the absence (Control) and presence
(EPA) of 5µM EPA. The currents were elicited by 10mV increment
voltage steps (20ms; 0.2 Hz) from a holding potential of −80mV down
to −90mV and up to 40mV. (Lower) Current-voltage relations of peak
INa in the absence (◦) and presence (•) of 5µM EPA.
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